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Intimate Partner Violence and Cervical Neoplasia
ANN L. COKER, Ph.D.,1 MAUREEN SANDERSON, Ph.D.,1 MARY KAY FADDEN, M.P.H.,1
and LUCIA PIRISI, M.D.2
ABSTRACT
Intimate partner violence (IPV) is associated with a range of adverse physical health outcomes,
including chronic and infectious diseases. An emerging literature suggests that partner vio-
lence and specifically sexual violence may be associated with an increased risk of cervical
neoplasia. To assess the risk of preinvasive and invasive cervical cancer in a cross-sectional
study of women screened for IPV by type, frequency and duration, 1152 women ages 18–65
were recruited from family practice clinics in 1997–1998. They were screened for IPV during
a brief in-clinic interview, and health history and current status were assessed in a follow-up
interview. Of 1152 women surveyed, 14 (1.2%) reported cervical cancer, and 20.3% (n 5 234)
reported treatment for cervical neoplasia. Ever experiencing IPV was associated with an in-
creased risk of invasive cervical cancer (adjusted relative risk [aRR] 5 4.28; 95% CI 1.94, 18.39)
and with preinvasive cervical neoplasia (aRR 5 1.47; 95% CI 1.16, 1.82). This association was
stronger for women experiencing physical or sexual IPV than for women experiencing psy-
chological IPV. Women with cervical cancer reported being in violent relationships longer
and experiencing more frequent physical and sexual assaults and more IPV-associated in-
juries than did controls. This exploratory study suggests that IPV may increase a woman’s
risk of cervical neoplasia. The mechanism by which IPV effects cervical neoplasia may be in-
direct through psychosocial stress or negative coping behaviors or direct through sexual as-
saults and transmission of human papillomavirus (HPV).
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INTRODUCTION
INTIMATE PARTNER VIOLENCE (IPV) is a significantpublic health problem that has both short-term
and long-term physical and mental health conse-
quences for women and their families.1,2 Preva-
lence estimates for current IPV among women re-
ceiving care in primary healthcare settings range
between 7% and 29%.3–6 Women experiencing
IPV use a disproportionate share of healthcare
services, making more visits to emergency de-
partments, primary care facilities, and mental
health agencies than nonabused women.7–12
Physical partner violence has mental and physi-
cal health consequences ranging from depression,
anxiety, and posttraumatic stress disorder to irri-
table bowel syndrome, migraine headaches,
angina, sexually transmitted infections (STI),
1Department of Epidemiology and Biostatistics, University of South Carolina, School of Public Health, Columbia,
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2Department of Pathology, University of South Carolina, School of Medicine, Columbia, South Carolina.
Funded by R49 CCR412752 of the CDC National Center for Injury Prevention and Control and the Disabilities Pre-
vention Program of the National Center for Environmental Health and by R29-CA-57466 from the National Institutes
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pelvic inflammatory disease, chronic pelvic pain,
and bladder, kidney, or other urinary tract infec-
tions.1,2,13–22
The mechanism by which sexual IPV affects
cervical neoplasia risk may be direct, through re-
peated sexual assaults that cause cervical trauma,
which in combination with introduction of hu-
man papillomavirus (HPV) might begin the cer-
vical carcinogenic process.24 Alternatively, phys-
ical or sexual IPV may affect cervical cancer risk
indirectly through increasing chronic stress,
which may suppress immune function25–28 and
thereby reduce the body’s ability to mount an ef-
fective immune response to HPV infection29,30 or
to appropriately detect and eliminate cervical tu-
mor cells.31,32
The purpose of this exploratory study was
twofold. First, we evaluated the association be-
tween IPV (by type of violence, duration, and fre-
quency of violence) and cervical neoplasia (by
cervical cancer or treatment for cervical lesions).
Second, we explored the potential mechanism by
which IPV might affect cervical neoplasia risk. To
our knowledge, this is the first study to address
IPV and cervical neoplasia, including cancer.
MATERIALS AND METHODS
Data collection
In this cross-sectional study, trained recruiters
approached and interviewed 1152 women seek-
ing medical care in two university-associated
family practice clinics from February 1997
through January 1999. Eligible subjects were
women ages 18–65 who were insured by either
Medicaid or a managed care provider. Because
we wanted to focus on partner violence, includ-
ing sexual violence, in intimate relationships, we
included only women who had ever been in an
intimate (meaning sexual) relationship with a
man for at least 3 months. Study participation in-
cluded a 5–10-minute in-clinic interview to screen
for partner violence and a 30–45-minute tele-
phone interview to assess the woman’s medical
history and current health status. We used com-
puter-assisted interviewing for both in-clinic and
telephone interviews to reduce errors and rapidly
provide scale scores for IPV measures. In-clinic
interviewers were women graduate students who
received extensive training in asking these sensi-
tive questions, in active listening, and in provid-
ing women with community resources. Women
were reimbursed for their time in completing
these interviews. Women currently in abusive re-
lationships were counseled by recruiters and re-
ferred to local services for victims. For safety rea-
sons, women currently in violent relationships
were given the option to complete this longer in-
terview in the clinic. All women signed consent
forms. The University of South Carolina Institu-
tional Review Board approved the project.
Measures of IPV
We characterized IPV by (1) the timing of the
violence (in any past or current intimate rela-
tionship), (2) the type of violence (physical, sex-
ual, or psychological violence), and (3) frequency
of the violence and injury. The instrumentation
methods for the study appear elsewhere.13,33 We
provide a brief overview here.
We used a modified (12-item) version of the 25-
item Index of Spouse Abuse–Physical34,35 (ISA-P)
to measure current or recent physical IPV and
sexual IPV and the Women’s Experience with
Battering (WEB) Scale to assess battering.36–38 We
also assessed past physical, sexual, and psycho-
logical IPV using a modification of the widely
used Abuse Assessment Screen.39 We combined
past and current IPV experience to hierarchically
categorize ever experiencing IPV by type: (1)
physical or sexual violence or both with or with-
out psychological IPV, (2) psychological violence,
defined to include either psychological battering
or emotion abuse without physical or sexual vi-
olence, and (3) never experiencing IPV as the ref-
erent group. The majority (88%) of women who
experienced physical or sexual violence also re-
ported psychological violence.
Psychometric properties of IPV measures. The
WEB Scale has good construct validity, accurately
discriminates battered from nonbattered
women,36,38 and shows strong internal consis-
tency reliability (Cronbach’s alpha 5 0.95 in our
sample of women receiving primary care). The
WEB Scale measures battering by operationaliz-
ing women’s psychological vulnerability or their
perceptions of susceptibility to physical and psy-
chological danger or loss of power and control in
a relationship with a male partner.36,37 The ISA-
P was designed to measure the frequency and
severity of physical assaults by an intimate part-
ner.34 As reported by Attala et al.35 in a valida-
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tion study of 135 women recruited from a bat-
tered women’s shelter and 48 nonabused women,
the 25-item measure is valid and reliable. The sen-
sitivity and specificity for a cut point of .2 were
87.5% and 96%, respectively, and the alpha coef-
ficient was 0.97. We assessed the reliability of the
full and modified scales in this study; the Cron-
bach’s alpha coefficients for the full 25-item scale
(n 5 89 pilot study) was 0.95, and the coefficient
for the full sample for the reduced 12-item scale
changed minimally (alpha 5 0.91). The Abuse
Assessment Screen (AAS)39 has been widely used
in clinical settings to rapidly assess IPV.
Psychological IPV was assessed for the current
or more recent relationship as well as in any past
relationship. Women scoring as battered
(WEB $ 20) yet not scoring as physically as-
saulted (ISA-P , 3) were defined as experiencing
psychological IPV in a current or most recent re-
lationship. Women who reported emotional
abuse without physical abuse on the AAS were
coded as experiencing psychological IPV in a past
relationship.
Frequency and duration of IPV and injuries. We
created frequency and duration scores for physi-
cal and sexual IPV. Duration was the length of
time the women reported being in an intimate re-
lationship in which there was IPV by the type of
violence. Frequency of physical IPV was assessed
based on the woman’s report of how frequently
the partner hit, slapped, kicked, or otherwise
physically hurt her during the time they were to-
gether as a couple. Frequency of sexual IPV was
assessed based on the woman’s report of how
frequently the partner forced sex on her during
their relationship. We addressed a dose-response
relationship between IPV and cervical neoplasia
by evaluating risk associated with (1) years in a
violent relationships, (2) frequency of injuries,
and (3) a cumulative duration times frequency
score for physical and sexual IPV. We created ter-
tiles of frequency-duration scores based on the
distribution of these scores among controls who
experienced IPV. There is overlap between the
two measures of sexual and physical IPV fre-
quency and duration. Women reporting higher
sexual IPV scores also report higher physical IPV
scores. However, we present the two measures
separately because the frequency measures are
specific to the type of violence and tap different
potential mechanisms.
Demographics
The following demographic characteristics
were assessed during the 5–10-minute in-clinic
screening interview: the woman’s current mari-
tal status, age, race/ethnicity, education, usual
occupation, age at first sexual intercourse, life-
time number of male sex partners, STI history,
pregnancy history, and cigarette smoking history.
Given the sensitive nature of the screening ques-
tions and limited interview time, we did not as-
sess childhood physical or sexual abuse. We did
ask about the father’s abusive behavior toward
the woman’s mother. We used this as a crude in-
dicator of possible child abuse.
Cervical neoplasia
In a subsequent 30–45-minute telephone sur-
vey conducted 1–2 weeks after the in-clinic sur-
vey, we assessed the prevalence of a range of
health outcomes13 using a modified National
Health Interview Survey.40 We asked women if
they had ever been diagnosed with a specific
(listed) cancer and if they had ever been treated
with “cryotherapy, laser therapy, or any other
treatment for an abnormal Pap smear.” We use
the label “cervical dysplasia” to refer to women
who were treated for an abnormal Pap smear but
who did not have cervical cancer. We used age
at first IPV experience as the reference date to cor-
rectly sequence cervical neoplasia as having oc-
curred only after the first IPV experience. From
these questions, we created the mutually exclu-
sive outcome variables of interest: cervical cancer
cases (n 5 14), cervical dysplasia cases (n 5 234),
and women with no reported history of cervical
neoplasia or other cancer as controls (n 5 847).
We additionally reviewed the medical records of
cervical cancer patients and those with dysplasia
to confirm the self-reported cervical neoplasia.
We did not have access to cervical cytology or
biopsy results to fully document the cervical le-
sions.
Statistical analysis
Unconditional polytomous multivariate logis-
tic regression41 was used to model the association
between IPV by type and cervical neoplasia, 
adjusting for age as a continuous variable, and
cigarette smoking (pack-years). Although this is
a cross-sectional study, we created time-framed 
exposures for smoking and partner violence,
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which stipulated that the exposures measured
had to have occurred prior to disease develop-
ment (age at cancer diagnosis or cervical neopla-
sia treatment). We enumerated only IPV experi-
ence and smoking duration prior to these ages of
diagnosis.
Because logistic regression provides odds ra-
tios (OR) that are biased estimates of the relative
risk (RR) if an outcome is not rare (.10%) (and
cervical dysplasia was not rare), we used the
method of Zhang and Yu42 to convert OR to RR.
We hypothesized that IPV might increase the
risk of cervical neoplasia directly by increasing
the risk of acquiring an STI, specifically HPV. To
address the role of STI in the association between
IPV and cervical neoplasia, we stratified by STI
status to determine whether STI might help clar-
ify the mechanism for the association.43
RESULTS
Response rates
Eleven percent of 1538 eligible women ap-
proached for participation (n 5 174) refused. Re-
fusers were significantly more likely to be insured
by Medicaid (32%) than were responders (25%).
We have no additional demographic data with
which to characterize refusers relative to respon-
ders. Of the responders, 14.1% did not complete
the health assessment interview (192 of 1364) or
had missing data on several response variables
(20 of 1364). Thus, 1152 women were included in
these analyses (75% response rate). Women who
completed the in-clinic interview but not the
health assessment interview (n 5 192) were
younger and significantly more likely to be in a
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TABLE 1. DISTRIBUTION OF RISK FACTORS FOR CERVICAL NEOPLASIA
Cervical Cervical
Relative Risk (95% CI)
cancer dysplasia Controls Cervical cancer Cervical dysplasia
Risk factor (n 5 14) (n 5 234) (n 5 847) cases vs. controls vs. controls
Agea 38.9 6 8.3 36.7 6 9.7 37.9 6 11.6 1.02 (0.98, 1.07) 0.99 (0.98, 1.01)
Age at first intercoursea 15.5 6 2.9 17.3 6 2.9 17.6 6 3.3 0.85 (0.75, 0.97) 0.98 (0.93, 1.02)
Lifetime number of male sex partnersa 8.1 6 6.4 8.5 6 15.6 7.7 6 17.0 1.00 (0.97, 1.03) 1.00 (0.99, 1.01)
No. of pregnanciesa 2.4 6 1.1 2.4 6 1.7 2.4 6 2.0 1.13 (0.91, 1.40) 0.99 (0.94, 1.07)
White raceb 35.7% 35.9% 38.7% 0.88 (0.29, 2.63) 0.91 (0.70, 1.16)
Medicaid insuranceb 14.3% 18.0% 22.6% 0.57 (0.13, 2.56) 0.75 (0.56, 1.07)
Educationb
,High school 28.6% 9.0% 12.4% 2.65 (0.79, 8.75) 0.72 (0.46, 1.09)
HS graduate or GED 14.3% 20.1% 21.4% 0.77 (0.16, 3.64) 0.88 (0.65, 1.21)
.HS education 57.1% 70.9% 66.2% 1.00 Refc 1.00 Ref
Currently divorced or separatedb 50.0% 24.8% 19.3% 4.14 (1.45, 11.62) 1.29 (0.96, 1.67)
Ever had sexually transmitted 35.7% 35.7% 17.4% 3.54 (1.22, 10.09) 1.89 (1.51, 2.33)
infectionb
Ever smoked cigarettesb 78.6% 37.6% 35.1% 6.64 (1.87, 22.51) 1.11 (0.83, 1.39)
Nonsmoker 21.4% 62.4% 64.9% 1.00 Refc 1.00 Ref
Current smokerb 78.6% 28.6% 26.0% 10.09 (2.87, 33.16) 1.12 (0.86, 1.44)
Years smoked cigarettesb
201 14.3% 0.4% 1.2% 32.38 (5.42, 126.86) 0.43 (0.06, 2.21)
10–20 28.6% 23.1% 19.6% 4.36 (0.98, 18.60) 1.18 (0.88, 1.55)
5–10 14.3% 8.1% 7.8% 5.36 (0.97, 29.87) 1.07 (0.67, 1.62)
,5 21.4% 6.0% 6.5% 9.67 (1.97, 42.67) 0.97 (0.57, 1.56)
Packs ususally smokedb
21 0.0% 1.7% 3.2% NEc 0.60 (0.22, 1.46)
1–2 35.6% 11.5% 10.7% 9.75 (2.36, 37.04) 1.10 (0.74, 1.57)
,1 43.0% 24.4% 21.0% 6.07 (1.53, 22.91) 1.17 (0.87, 1.52)
Pack-years smokingb
101 28.6% 12.0% 11.5% 7.39 (1.67, 30.50) 1.07 (0.73, 1.53)
5–10 14.3% 8.1% 9.1% 4.70 (0.79, 26.21) 0.94 (0.60, 1.44)
,5 35.7% 17.5% 14.4% 7.35 (1.77, 28.56) 1.21 (0.87, 1.64)
aMean 6 SD.
b% within case group.
cRef, referent; NE, not estimable.
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current violent relationship (RR 5 2.6) than were
women who completed the health assessment.
The prevalence of partner violence was rela-
tively high in this clinic population; 53.7% had
ever experienced some type of IPV. Among those
reporting IPV, 77% experienced physical or sex-
ual IPV, and 23% experienced psychological vio-
lence without physical or sexual IPV.
Table 1 provides our assessment of risk factors
for cervical neoplasia in this population. Cervical
cancer patients had earlier ages at first inter-
course and were more likely to be divorced or
separated, and to smoke than other women.
Those with cervical cancer or cervical dysplasia
were also more likely than controls to have ever
had STI.
Table 2 presents the frequency of IPV by type
among women with cervical cancer, cervical dys-
plasia, and controls. Ever experiencing IPV was
more strongly associated with cervical cancer
(RR 5 4.47; 95% CI 1.07, 19.07) than with cervical
dysplasia (RR 5 1.60; 95% CI 1.18, 2.15). For cer-
vical cancer cases relative to controls, the associ-
ation with IPV was strongest for physical and sex-
ual IPV (adjusted RR [aRR] 5 7.18). Increasing
duration in a violent relationship, increasing IPV-
associated injuries, and increasing physical and
sexual IPV frequency-duration scores were all as-
sociated with increasing cervical cancer risk in a
dose-dependent manner. For cervical dysplasia
relative to controls, physical or sexual IPV was
significantly associated with increased risk, yet
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TABLE 2. RISK OF CERVICAL NEOPLASIA ASSOCIATED WITH INTIMATE PARTNER
VIOLENCE BY TYPE, SEVERITY, AND DURATION OF VIOLENCE
Cervical Cervical
Adjusted RRa (95% CI)
cancer dysplasia Controls Cervical cancer Cervical dysplasia
Intimate partner violence (IPV) (n 5 14) (n 5 234) (n 5 847) cases vs. controls vs. controls
Ever experienced any IPV 85.7% 62.4% 50.8% 4.47 (1.07, 19.07) 1.60 (1.18, 2.15)
(physical, sexual, or psychological)
Ever experienced IPV by type
No IPV 14.3% 37.6% 49.2% 1.00 Refa 1.00 Ref
Psychological, no physical IPV 14.3% 13.7% 11.8% 3.77 (0.53, 25.00) 1.38 (0.96, 1.92)
Physical, no sexual IPV 14.3% 25.2% 19.5% 1.80 (0.28, 12.81) 1.50 (1.11, 1.95)
Physical and sexual IPV 57.1% 23.5% 19.5% 7.18 (1.51, 31.54) 1.44 (1.07, 1.90)
Years in violent relationship
No IPV 14.3% 45.7% 54.9% 1.00 Ref 1.00 Ref
1–5 14.3% 28.2% 25.1% 1.68 (0.23, 11.27) 1.24 (0.93, 1.62)
5–10 21.4% 11.1% 8.4% 6.59 (1.07, 36.37) 1.44 (0.97, 2.03)
101 50.0% 15.0% 11.6% 13.04 (2.64, 53.29) 1.49 (1.04, 2.04)
Wald chi-square for trend (p value) 12.47 (0.0004) 6.71 (0.01)
IPV-associated injury score
No injury 28.6% 66.7% 72.1% 1.00 Ref 1.00 Ref
1–2 35.7% 23.1% 18.4% 3.04 (0.84, 10.75) 1.26 (0.94, 1.64)
.2 35.7% 10.3% 9.4% 4.54 (1.19, 16.77) 1.14 (0.76, 1.67)
Wald chi-square test for trend (p value) 5.57 (0.02) 1.57 (0.21)
Physical IPV scoreb
No physical IPV 28.6% 58.5% 64.7% 1.00 Ref 1.00 Ref
Q1a 0.0% 13.7% 11.6% NEa 1.20 (0.83, 1.68)
Q2 21.4% 12.4% 12.0% 3.22 (0.70, 145.30) 1.10 (0.74, 1.55)
Q3 50.0% 15.4% 11.7% 6.84 (1.88, 23.69) 1.39 (0.98, 1.90)
Wald chi-square test for trend (p value) 9.09 (0.003) 3.16 (0.08)
Sexual IPV scoreb
No sexual IPV 42.9% 76.5% 80.5% 1.00 Ref 1.00 Ref
Q1 0% 4.7% 6.1% NE 0.83 (0.45, 1.42)
Q2 7.1% 10.7% 6.8% 1.40 (0.16, 11.79) 1.49 (0.98, 2.05)
Q3 50.0% 8.1% 6.5% 11.15 (3.58, 32.70) 1.31 (0.83, 1.95)
Wald chi-square test for trend (p value) 13.89 (0.0002) 3.07 (0.08)
aRef, referent; Q, quartile; NE, not estimable; RR, relative risk.
bScore includes frequency of violence multiplied by duration in a violent relationship.
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increasing frequency and duration scores were
not significantly associated with increased cervi-
cal dysplasia risk.
Table 3 shows the risk of cervical neoplasia as-
sociated with physical and sexual IPV frequency-
duration scores by STI history. We found that
higher sexual IPV scores (quartile 3) were associ-
ated with cervical cancer among women both
with (RR 5 10.4) and without (RR 5 11.2) a his-
tory of an STI. Higher physical IPV scores (quar-
tile 3) were significantly associated with cervical
cancer only among those without an STI history.
Similarly, increasing physical IPV scores (quartile
3) were associated with an increased risk of cer-
vical dysplasia risk only among women who had
never had an STI. This analysis is based on very
small numbers and should be treated as ex-
ploratory in nature.
DISCUSSION
We found evidence for an association between
IPV and cervical cancer. Further, risk of cervical
cancer was associated with increasing IPV dura-
tion and frequency in a dose-dependent manner
for both physical and sexual IPV. Although cer-
vical dysplasia was associated with ever experi-
encing IPV, no dose-dependent association was
observed.
Our finding that IPV is associated both with
having an STI and with cervical cancer is consis-
tent with findings of others who reported associ-
ations between IPV and STI, pelvic inflammatory
disease, chronic pelvic pain, and bladder, kidney,
or other urinary tract infections.13,19–22 These
findings are also consistent with the growing lit-
erature showing that sexual assaults and abuse
are associated with an increased risk of an STI,44
including infection with human immunodefi-
ciency virus (HIV)45 and HPV,46 and with an in-
creased risk of cervical dysplasia.24 Furthermore,
it is clear that IPV has physical health effects on
women beyond STI and injuries.1,2,7–15,47–50
We found evidence that IPV may be associated
with cervical cancer indirectly through chronic
stress and through an STI. If IPV were directly
linked to cervical neoplasia through increasing
risk of an STI, the RR for IPV and cervical neo-
plasia should be strongest within the strata of
women with an STI, and IPV should not be as-
sociated with cervical neoplasia among women
without an STI. If IPV were indirectly linked to
cervical neoplasia through chronic stress, we
might expect no difference in the stratum-specific
RR. We did find that physical IPV scores were as-
sociated with cervical cancer among women both
with and without a history of an STI. Interest-
ingly, physical IPV scores were associated with
cervical dysplasia and cancer only among women
with no history of an STI. This supports the
chronic stress mechanism for IPV’s association
with cervical neoplasia. By chronic stress, we
mean the impact of anxiety and perceived stress
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TABLE 3. RISK OF CERVICAL NEOPLASIA ASSOCIATED WITH PHYSICAL AND SEXUAL IPV SCORE BY STI HISTORY
Cervical cancer Cervical dysplasia
Ever STI Never STI Ever STI Never STI
Sexual IPV scorea
Quartile 3 4/17b 3/38 7/17 12/38
10.4 (1.8, 51.5) 11.2 (2.5, 44.9) 0.8 (0.3, 1.7) 1.3 (0.7, 2.1)
Quartiles 1–2 0/38 1/72 20/38 16/72
NEc 2.0 (0.2, 17.4) 1.0 (0.5, 1.6) 1.0 (0.6, 1.6)
No sexual IPV 2/92 4/590 50/92 129/590
1.0 Refc 1.0 Ref 1.0 Ref 1.0 Ref
Physical IPV scorea
Quartile 3 4/28 3/71 10/28 26/71
4.1 (0.7, 21.7) 10.0 (1.7, 51.0) 0.6 (0.3, 1.3) 1.5 (1.1, 2.1)
Quartiles 1–2 0/62 3/138 34/62 27/138
NE 5.2 (0.9, 28.9) 0.9 (0.5, 1.5) 0.9 (0.6, 1.4)
No sexual IPV 2/65 2/491 33/57 104/491
1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
aScore includes frequency of violence multiplied by duration in a violent relationship.
bCases/controls; RR (95% CI).
cNE, not estimable; Ref, referent.
Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.
associated with partner violence; this violence
may occur over long periods of time and is un-
predictable for the victim. Caution must be ap-
plied in interpreting these results, given the small
numbers.
This report should be treated as exploratory or
hypothesis generating in nature. As is true for ex-
ploratory studies, there are a number of limita-
tions to their early work. STI was measured here
based on the women’s self-report. We do not have
laboratory tests to confirm this history, nor do we
have a measure of the etiological agent in cervi-
cal neoplasia, HPV. Additionally, we have no in-
formation on the HPV status of women’s male
partners. We undoubtedly misclassified STI ex-
posure, but probably in a nondifferential manner,
thus biasing the resulting RR toward the null.
However, as we found that having a history of
an STI was associated with both cervical cancer
and dysplasia, we believe that this crude measure
is a reasonable proxy. Another limitation of this
study is the small number of invasive cervical
cancer cases (n 5 14) and our inability to specifi-
cally identify the grade of dysplasia. We were,
however, able to verify through medical records
that the self-reported cancers were indeed can-
cers. Further, because we asked about specific
surgical treatment for an abnormal Pap smear, we
are confident that women did have a high-grade
or low-grade squamous intraepithelial lesion and
not cervical atypia or inflammation. However,
this group of women reporting treatment for a
cervical lesion is heterogeneous and includes
those with high-grade precancerous lesions and
those with low-grade lesions. We might expect
then that IPV would be more strongly associated
with invasive cancer relative to this heteroge-
neous group of women with cervical lesions rang-
ing in severity. Although this is a cross-sectional
study, we were able to create temporally correct
exposure measures for IPV, smoking, and STI as
those prior to cervical neoplasia development
and, thus, approximate an incident case-control
study.
Because ensuring women’s safety was a major
concern, we did not wish to conduct follow-up
phone interviews if women did not believe this
was safe. We, therefore, disproportionately lost
women currently in violent relationships. The
prevalence of IPV in a current relationship among
those completing the screener questionnaire was
7.3%, and the IPV prevalence among those com-
pleting the follow-up questionnaire was 5.7%. We
explored whether this potential selection bias
might affect our study findings by looking at the
timing of IPV in a relationship and reporting cer-
vical neoplasia. The crude OR for the association
between IPV and cervical neoplasia were similar
across different periods of IPV experience and
suggest that our differential loss of those cur-
rently in violent relationships did not bias the re-
sulting OR for IPV and cervical neoplasia (OR for
IPV in a current relationship and cervical
cancer 5 4.0, dysplasia 5 1.20; OR for IPV in a re-
cent relationship and cervical cancer 5 3.8, dys-
plasia 5 1.35; OR for IPV in a past relationship
and cervical cancer 5 3.0, dysplasia 5 1.45).
To our knowledge, this is the first study to re-
port an association between IPV and cervical neo-
plasia, including cancers. This study is relatively
large (n 5 1152), and we carefully measured IPV
by the type (physical, sexual, and psychological
violence), the frequency of the violence, and the
duration in the violent relationship to assess the
dose-dependent association between IPV and cer-
vical neoplasia. We adjusted for the most signif-
icant confounders in these data (smoking and
age), and we explored a possible mechanism by
which IPV might be linked to cervical neoplasia.
CONCLUSIONS
These exploratory data suggest that IPV may
be associated with higher-grade cervical lesions.
However, additional, larger studies are needed to
test this hypothesis. Further studies should in-
clude biological markers of HPV infection, eval-
uate the role of IPV and other chronic stressors
on cervical neoplasia, and address the possibility
that IPV and other chronic stressors may cause
delayed Pap smear screening and, thereby, be as-
sociated with an increased risk of being detected
with a higher-grade cervical lesion.
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